Doctor Florian Kahles

Back

Doctor Florian Kahles

RWTH University Hospital Aachen, Aachen (Germany)

Presentations

High-sensitivity C-reactive protein: how can it guide cardiovascular risk assessment?

Event: ESC Congress 2024

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Systemic inflammation in stable and unstable ischaemic heart disease (IHD): connecting the dots

Access

GLP-2 predicts cardiovascular outcomes in patients with myocardial infarction and increases atherosclerosis in mice

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Bench to bedside in acute coronary syndromes: from infarction size in animal studies to long-term development of chronic coronary syndrome

Access

GLP-2 as an indicator and modulator of acute inflammation improves cardiac function and survival in sepsis

Event: ESC Congress 2022

Topic: Leukocytes, Inflammation, Immunity

Session: Acquired forms of heart failure: cancer and inflammatory disorders

Access

The gut hormone GIP predicts CV prognosis in patients with acute myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Access

The gut hormone GLP-2 predicts cardiovascular risk in patients with acute myocardial infarction

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Access

Activation of the GIP system attenuates pathological vascular remodeling by decreasing infiltration and proinflammatory activation of monocytes in ApoE-/- mice

Event: ESC Congress 2017

Topic: Inflammation, growth factors and signal transduction-vascular

Session: Vascular inflammation

Access

The PDE-4 inhibitor roflumilast reduces body weight and improves glucose metabolism by increasing energy expenditure and mitochondrial respiration

Event: ESC Congress 2016

Topic: Metabolism and metabolic syndromes

Session: Integrative physiology and pathology

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Florian Kahles Follow

Contributor content

High-sensitivity C-reactive protein: how can it guide cardiovascular risk assessment?

GLP-2 predicts cardiovascular outcomes in patients with myocardial infarction and increases atherosclerosis in mice

GLP-2 as an indicator and modulator of acute inflammation improves cardiac function and survival in sepsis

The gut hormone GIP predicts CV prognosis in patients with acute myocardial infarction

The gut hormone GLP-2 predicts cardiovascular risk in patients with acute myocardial infarction

Activation of the GIP system attenuates pathological vascular remodeling by decreasing infiltration and proinflammatory activation of monocytes in ApoE-/- mice

The PDE-4 inhibitor roflumilast reduces body weight and improves glucose metabolism by increasing energy expenditure and mitochondrial respiration

ESC 365 is supported by

Doctor Florian Kahles